United States Pressure Ulcer Prevention Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

United States Pressure Ulcer Prevention Market Trends and Insights

Aging, Immobile, and Critically Ill Patient Base

The aging population remains the most durable demand base for the pressure ulcer prevention market because older adults are more likely to experience immobility, frailty, and longer inpatient stays. Baby boomers were in the 61 to 79 age range in 2025, which means the United States continues to carry a large cohort of patients who are more exposed to pressure injury risk across hospitals, long-term care sites, and home settings.^{[1]U.S. Census Bureau, “U.S. Population Aging as Nation Turns 250,” Census Bureau Stories, census.gov} That demographic shift matters because prevention spending rises not only with patient numbers, but also with the severity and duration of care required for each high-risk admission. The product mix is also moving upward in value because older patients increasingly present with obesity, cardiovascular conditions, and other comorbidities that require bariatric-rated surfaces and better moisture control. This pattern gives the pressure ulcer prevention market a broader revenue base than simple bed occupancy growth would suggest.

HAPI Cost and Quality-Of-Care Penalties

Hospital-acquired pressure injuries now sit much closer to executive decision making because they affect cost control, care quality, and reputational risk at the same time. The pressure ulcer prevention market benefits from this shift because provider systems are putting more weight on prevention pathways that can be standardized, tracked, and defended during quality review. Cleveland Clinic reported a 36% reduction in hospital-acquired pressure injuries between 2024 and 2025 after implementing a systematic interprofessional prevention protocol, which shows that hospitals are willing to scale structured prevention when the operational case is clear.^{[2]Cleveland Clinic, “Protecting the Body’s Largest Organ: Nurse-Led Strategy Reduces Hospital-Acquired Pressure Injuries,” Consult QD, clevelandclinic.org} Documentation standards are also becoming more important because facilities need stronger admission records and clearer proof of prevention activity throughout the patient's stay. That increases the appeal of products and workflows that support early assessment, consistent care delivery, and auditable records across nursing teams.

Homecare and Post-Discharge Prevention Demand

Homecare is becoming a larger growth engine for the pressure ulcer prevention market as discharge happens earlier and more preventive care moves outside institutional walls. This shift does not reduce risk, because many patients still leave acute care with limited mobility, fragile skin, and ongoing caregiver dependence after discharge. A 2025 JMIR Nursing study developed an AI-assisted decision support tool for home-visiting nurses managing pressure injuries and achieved expert-level agreement of 0.92 during validation, which supports the idea that home-based prevention can move closer to institutional clinical quality when guidance tools are in place.^{[3]JMIR Nursing, “An Expert Knowledge Algorithm and Model Predicting Wound Healing Trends for a Decision Support System for Pressure Injury Management in Home Care Nursing: Development and Validation Study,” JMIR Nursing, jmir.org} The channel implication is significant because family caregivers and home health agencies need different products, packaging, and training than hospital buyers. That is why the pressure ulcer prevention market is opening new room for direct homecare distribution, simpler repositioning tools, and easy-to-use skin protection products.

Better Support Surfaces and Prophylactic Dressings

The pressure ulcer prevention market is also being lifted by better products that address pressure, friction, shear, and moisture together instead of treating them as separate problems. Smith+Nephew launched ALLEVYN COMPLETE CARE Foam Dressing in the United States in March 2026 with ShearDEFENSE Technology and reported 93% mechanical energy absorption along with clinical evidence of more than 65% pressure injury risk reduction. In January 2025, ECRI upgraded its Evidence Bar ratings for ALLEVYN LIFE Sacrum Foam Dressing and the LEAF Patient Monitoring System to favorable, which matters because hospital committees often rely on third-party evidence review when making formulary decisions. This makes evidence quality a practical barrier to entry for suppliers that lack peer-reviewed support or independent assessment. It also shortens the commercial life of older foam products that cannot match newer outcome data.

High Capital and Replacement Cost of Advanced Surfaces

High acquisition and replacement costs continue to limit how quickly the pressure ulcer prevention market can move deeper into smaller hospitals and nursing facilities. Advanced alternating-pressure and low-air-loss systems offer better clinical capability, but they also bring ongoing costs tied to maintenance, replacement covers, pumps, and staff familiarization. Rental models reduce the first purchase hurdle, yet they can also create dependence on third parties and slow standardization across a care network. This gap is most visible in rural hospitals and smaller skilled nursing facilities where prevention budgets compete directly with labor needs and other essential expenses. The result is a two-speed pressure ulcer prevention market in which large health systems upgrade faster while smaller sites stay on older or lower-specification surfaces.

Variable Adherence to Turning and Skin-Assessment Protocols

Clinical execution remains a major restraint because better products do not produce full value when repositioning, and skin checks are inconsistent. ANEDIDIC reported in 2025 that 95% of pressure injuries are clinically preventable, while still identifying caregiver knowledge and execution as the decisive barrier to better outcomes. Cleveland Clinic showed the opposite side of the issue when its structured interprofessional protocol reduced hospital-acquired pressure injuries by 36% between 2024 and 2025 through systematic execution rather than new hardware alone. This means adherence tools, wearable compliance devices, and digital documentation systems are becoming commercially relevant alongside mattresses and dressings. Vendors that solve the workflow problem as well as the product problem will be better placed in the pressure ulcer prevention market.

Segment Analysis

By Product Type: Advanced Surfaces Hold the Largest Base While Skin Protection Moves Faster

Support surfaces captured 62.87% of revenue in 2025, which gave them the largest share within the pressure ulcer prevention market because critical care and perioperative settings still rely on active redistribution as a core prevention measure. This high share reflects the fact that ICU, step-down, and higher-acuity patients often need continuous support that basic surfaces cannot provide consistently. Dynamic systems such as alternating-air, low-air-loss, and lateral rotation platforms continue to command a larger portion of value because they are used for patients with the greatest risk exposure and the highest level of monitoring. Arjo remains well placed in this part of the pressure ulcer prevention market through platforms such as AtmosAir Velaris and Auralis, which support both standard and bariatric care needs across acute settings. Static foam, gel overlays, and hybrid reactive formats remain important in long-term care and home settings where budget discipline is tighter, and product simplicity matters more than full dynamic capability.

Skin protection products are projected to grow at 6.36% CAGR through 2031, which makes them the fastest-growing product category within the pressure ulcer prevention market. That growth reflects wider use of barrier films, no-sting protectants, and preventive skin management in perioperative pathways, ambulatory care, and discharge planning. The pressure ulcer prevention market size for Skin Protection Products is rising because these items are easier to standardize, easier to distribute into non-acute channels, and easier for caregivers to use outside clinical facilities. Prophylactic dressing innovation also supports the category because stronger evidence around friction and shear reduction encourages broader protocol adoption. Detection and Monitoring Technologies remain the smallest segment today, but institutional interest is increasing as providers seek earlier risk visibility and better workflow documentation, and Bruin Biometrics reported that its Provizio SEM Scanner had exceeded 1 million patient scans since commercialization, with an estimated 50,000 reportable pressure injuries prevented.

By End User: Hospitals Lead Current Spending While Homecare Changes the Next Phase

Hospitals & ambulatory surgery centers held 56.83% of end-user revenue in 2025, which gave them the leading position in the pressure ulcer prevention market share because the most severe risk still concentrates in inpatient and procedural care. This lead reflects the high burden seen in ICUs, step-down units, and perioperative suites where patients are immobile, medically complex, and often unable to reposition themselves. Device-related pressure injuries add another layer of need in these settings because masks, tubes, and other equipment create localized risk that standard surfaces alone cannot fully offset. Large hospitals are therefore the first buyers of evidence-backed surfaces, prophylactic dressings, early assessment tools, and workflow systems that support documentation and protocol consistency. Clinics and wound care centers are also gaining a larger role because many health systems now use them to stabilize patients during discharge transitions before care moves fully into the home.

Homecare settings are projected to expand at 7.37% CAGR through 2031, making them the fastest-growing end-user category in the pressure ulcer prevention market. This trend is being driven by earlier discharge, hospice expansion, and the transfer of prevention responsibility from staffed clinical settings to caregivers who need practical tools and clearer guidance. Long Term Care & Urgent Care Centers remain the second-largest institutional channel because they serve people with ongoing immobility risk and frequent dependence on Medicaid-linked reimbursement. The pressure ulcer prevention market size for Homecare Settings is increasing as caregivers need products that are easy to apply, easy to purchase, and simple to use without clinical training, which differs sharply from hospital-centered portfolios. That mismatch leaves a visible opening for manufacturers that can tailor products and packaging to caregiver-managed prevention instead of relying on repurposed institutional formats.

Geography Analysis

The United States pressure ulcer prevention market shows clear regional variation in patient mix, care settings, and product preferences. The Southeast, led by Florida, Georgia, and the Carolinas, carries a large share of older adults and therefore a larger base of patients with immobility-related risk. That profile supports strong demand across skilled nursing facilities, assisted living centers, and homecare providers that manage long-duration prevention needs. Pressure ulcer prevention market share is therefore supported by volume in the Southeast, even though a large part of demand remains concentrated in lower-cost surfaces and barrier products. Springer Nature reported persistent U.S. disparities in deaths with documented pressure injuries that track uneven care access and high rates of cardiovascular disease and diabetes, and those conditions remain overrepresented in several Southeastern care populations.

The Northeast and Mid-Atlantic corridor remains the strongest premium-tier adoption zone within the pressure ulcer prevention market. Academic medical centers in Boston, New York, Philadelphia, and nearby health systems are more likely to adopt evidence-backed dressings, early detection tools, and advanced workflows because they combine research capacity with large purchasing contracts. That environment helps newer technologies move faster from evaluation to protocol adoption. Cleveland Clinic’s 2025 quality-improvement results also reinforce how major systems in this broad corridor are setting visible benchmarks for HAPI reduction through structured prevention programs.

The Midwest presents a split picture for the pressure ulcer prevention market because large integrated delivery networks coexist with rural hospitals that face tighter capital limits. States such as Ohio, Illinois, Minnesota, and Michigan include sophisticated prevention programs, but they also include smaller facilities that cannot upgrade surfaces as quickly. Western states, especially California and Washington, are pushing prevention toward more digitally connected post-discharge care models. That makes the pressure ulcer prevention market more service-oriented in the West, with greater interest in remote assessment support, homecare continuity, and products that fit telehealth-linked care pathways.